15-hydroxy-6α,12-epoxy-7β,10αH,11βH-spiroax-4-ene-12-one sensitizes rectal tumor cells to anti-PD1 treatment through agonism of CD11b

References

• Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012;30(16):1926–1933.
   PubMed Web of Science ®Google Scholar
• Valentini V, van Stiphout RG, Lammering G, et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol. 2011;29(23):3163–3172.
   PubMed Web of Science ®Google Scholar
• Lange MM, Martz JE, Ramdeen B, et al. Long-term results of rectal cancer surgery with a systematical operativeapproach. Ann Surg Oncol. 2013;20(6):1806–1815.
   PubMed Web of Science ®Google Scholar
• Wolchok JD, Kluger H, Callahan MK, et al. Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med. 2013;369(2):122–133.
   PubMed Web of Science ®Google Scholar
• Wilkie KP, Hahnfeldt P. Tumor-immune dynamics regulated in the microenvironment inform the transient nature of immune-induced tumor dormancy. Cancer Res. 2013;73(12):3534–3544.
   PubMed Web of Science ®Google Scholar
• Qian B-Z, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39–51.
   PubMed Web of Science ®Google Scholar
• Qian BZ, Li J, Zhang H, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475(7355):222–225.
   PubMed Web of Science ®Google Scholar
• Napolitano M, D'Alterio C, Cardone E, et al. Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients. Oncotarget. 2015;6(10):8261–8270.
   PubMedGoogle Scholar
• McFarland HI, Nahill SR, Maciaszek JW, et al. CD11b (Mac-1): a marker forCD8+ cytotoxic T cell activation and memory in virus infection. J Immunol. 1992;149(4):1326–1333.
   PubMed Web of Science ®Google Scholar
• Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122(3):787–795.
   PubMed Web of Science ®Google Scholar
• Jaeschke H, Farhood A, Bautista AP, et al. Functionalinactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protectsagainst ischemia-reperfusion injury in rat liver. Hepatology. 1993;17(5):915–923.
   PubMed Web of Science ®Google Scholar
• Celik E, Faridi MH, Kumar V, et al. Agonist leukadherin-1 increases CD11b/CD18-dependent adhesion via membrane tethers. Biophys J. 2013;105(11):2517–2527.
   PubMed Web of Science ®Google Scholar
• Dove A. CD18 trials disappoint again. Nat Biotechnol. 2000;18(8):817–818.
   PubMed Web of Science ®Google Scholar
• Zheng C, Chen Y, Jiang LL, et al. Antiproliferative metabolites from the endophytic fungus penicillium sp. FJ-1 isolated from a mangrove Avivennia marina. Phytochem Lett. 2014;10:272–275.
   Web of Science ®Google Scholar
• Faridi MH, Khan SQ, Zhao W, et al. CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus. J Clin Invest. 2017;127(4):1271–1283.
   PubMed Web of Science ®Google Scholar
• Maiguel D, Faridi MH, Wei C, et al. Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease. Sci Signal. 2011;4(189):ra57.
   PubMed Web of Science ®Google Scholar
• Xie C, Zhu J, Chen X, et al. Structure of an integrin with an alphaI domain, complement receptor type 4. Embo J. 2010;29(3):666–679.
   PubMed Web of Science ®Google Scholar
• Moon EK, Ranganathan R, Eruslanov E, et al. Blockade of programmed death 1 augments the ability of human T cells engineered to target NY-ESO-1 to control tumor growth after adoptive transfer. Clin Cancer Res. 2016;22(2):436–447.
   PubMed Web of Science ®Google Scholar
• Ostrand-Rosenberg S. Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity. Cancer Immunol Immunother. 2010;59(10):1593–1600.
   PubMed Web of Science ®Google Scholar
• Guan Y, Zhang R, Peng Z, et al. Inhibition of IL-18-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy against osteosarcoma cancer. J Bone Oncol. 2017;9:59–64.
   PubMed Web of Science ®Google Scholar
• Yang L, Wang B, Qin J, et al. Blockade of CCR5-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy in gastric cancer. Immunopharmacol Immunotoxicol. 2018;40(1):91–97.
   PubMed Web of Science ®Google Scholar
• Ino Y, Yamazaki-Itoh R, Shimada K, et al. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br J Cancer. 2013;108(4):914–923.
   PubMed Web of Science ®Google Scholar
• Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348(6230):56–61.
   PubMed Web of Science ®Google Scholar
• Teng MW, Ngiow SF, Ribas A, et al. Classifying cancers based on T-cell Infiltration and PD-L1 . Cancer Res. 2015;75(11):2139–2145.
   PubMed Web of Science ®Google Scholar
• Khaled YS, Ammori BJ, Elkord E. Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients. J Immunol Res. 2014;2014:879897.
   PubMed Web of Science ®Google Scholar
• Lu C, Redd PS, Lee JR, et al. The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells. Oncoimmunology. 2016;5(12):e1247135.
   PubMed Web of Science ®Google Scholar
• Bronte V, Brandau S, Chen SH, et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun. 2016;7:12150.
   PubMed Web of Science ®Google Scholar
• Bayne LJ, Beatty GL, Jhala N, et al. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell. 2012;21(6):822–835.
   PubMed Web of Science ®Google Scholar
• Zhang QW, Liu L, Gong CY, et al. Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS One. 2012;7(12):e50946.
   PubMed Web of Science ®Google Scholar
• Mitchem JB, Brennan DJ, Knolhoff BL, et al. Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. Cancer Res. 2013;73(3):1128–1141.
   PubMed Web of Science ®Google Scholar
• Gahmberg CG. Leukocyte adhesion: CD11/CD18 integrins and intercellular adhesion molecules. Curr Opin Cell Biol. 1997;9(5):643–650.
   PubMed Web of Science ®Google Scholar
• Schmid MC, Khan SQ, Kaneda MM, et al. Integrin CD11b activation drives anti-tumor innate immunity . Nat Commun. 2018;9(1):5379.
   PubMedGoogle Scholar